0000950142-24-001494.txt : 20240530
0000950142-24-001494.hdr.sgml : 20240530
20240530181110
ACCESSION NUMBER: 0000950142-24-001494
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240530
FILED AS OF DATE: 20240530
DATE AS OF CHANGE: 20240530
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MANHARD KIMBERLY
CENTRAL INDEX KEY: 0001202094
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-42031
FILM NUMBER: 241007002
MAIL ADDRESS:
STREET 1: C/O HERON THERAPEUTICS, INC
STREET 2: 4242 CAMPUS POINT COURT, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inhibrx Biosciences, Inc.
CENTRAL INDEX KEY: 0002007919
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 990613523
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11025 N. TORREY PINES ROAD, SUITE 140
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: (858) 795-4220
MAIL ADDRESS:
STREET 1: 11025 N. TORREY PINES ROAD, SUITE 140
CITY: LA JOLLA
STATE: CA
ZIP: 92037
FORMER COMPANY:
FORMER CONFORMED NAME: Ibex SpinCo, Inc.
DATE OF NAME CHANGE: 20240111
4
1
es240484864_4-manhard.xml
OWNERSHIP DOCUMENT
X0508
4
2024-05-30
0
0002007919
Inhibrx Biosciences, Inc.
INXB
0001202094
MANHARD KIMBERLY
C/O INHIBRX BIOSCIENCES, INC.
11025 NORTH TORREY PINES ROAD, SUITE 140
LA JOLLA
CA
92037
1
0
0
0
0
Stock Option (right to buy)
15.86
2024-05-30
4
A
0
30000
0.00
A
2034-05-30
Common Stock
30000
30000
D
This stock option was granted following the consummation of the merger of Inhibrx, Inc. with a wholly owned indirect subsidiary of Sanofi.
This stock option will be fully exercisable on May 30, 2025, subject to the reporting person's continued service through such date.
/s/ Kelly D. Deck, Chief Financial Officer of Inhibrx Biosciences, Inc., attorney-in-fact
2024-05-30